PL
PGNY icon

Pluribus Labs’s Progyny PGNY Stock Holding History

Pluribus Labs’s Portfolio PGNY Stock Details PGNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,605
Closed -$232K – 179
2021
Q4 		$232K Buy
+4,605
New +$258K 0.24% 185

Other funds holding PGNY

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pluribus Labs's PGNY Position: Q1 2022 in Review

Pluribus Labs sold out of Progyny (PGNY) in Q1 2022, closing a stake of 4,605 shares — an estimated $232K sold.

Pluribus Labs first reported a position in PGNY in Q4 2021 and held it in 1 quarter. The position peaked at $232K in Q4 2021. 255 funds tracked by Wall St. Rank hold PGNY as of Q1 2022.

  • Pluribus Labs reported no remaining Progyny position as of Q1 2022 after selling out during the quarter.
  • Pluribus Labs sold 4,605 Progyny shares in Q1 2022, an estimated $232K.
  • Pluribus Labs first reported a position in Progyny in Q4 2021 and held it in 1 quarter.
  • Pluribus Labs's Progyny position peaked at $232K in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Progyny as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.